Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases

Omer N. Koç, Charles Peters, Patrick Aubourg, Shrini Raghavan, Stephanie Dyhouse, Rita Degasperi, Edwin H. Kolodny, Yoav Benyoseph, Stanton L. Gerson, Hillard M. Lazarus, Arnold I. Caplan, Paul A Watkins, William Krivit

Research output: Contribution to journalArticle

Abstract

Human bone marrow contains mesenchymal stem cells (MSCs) that can differentiate into various cells of mesenchymal origin. We developed an efficient method of isolating and culture expanding a homogenous population of MSCs from bone marrow and determined that MSCs express α-L-iduronidase, arylsulfatase-A and B, glucocerebrosidase, and adrenoleukodystrophy protein. These findings raised the possibility that MSCs may be useful in the treatment of storage disorders. To determine if donor derived MSCs are transferred to the recipients with lysosomal or peroxisomal storage diseases by allogeneic hematopoietic stem cell (HSC) transplantation, we investigated bone marrow derived MSCs of 13 patients 1-14 years after allogeneic transplantation. Highly purified MSCs were genotyped either by fluorescence in situ hybridization using probes for X and Y-chromosomes in gender mis- matched recipients or by radiolabeled PCR amplification of polymorphic simple sequence repeats. Phenotype was determined by the measurement of disease specific protein/enzyme activity in purified MSCs. We found that MSCs isolated from recipients of allogeneic HSC transplantation are not of donor genotype and have persistent phenotypic defects despite successful donor type hematopoietic engraftment. Whether culture expanded normal MSCs can be successfully transplanted into patients with storage diseases and provide therapeutic benefit needs to be determined.

Original languageEnglish (US)
Pages (from-to)1675-1681
Number of pages7
JournalExperimental Hematology
Volume27
Issue number11
DOIs
StatePublished - Nov 1999

Fingerprint

Lysosomal Storage Diseases
Homologous Transplantation
Mesenchymal Stromal Cells
Bone Marrow
Hematopoietic Stem Cell Transplantation
Tissue Donors
Iduronidase
N-Acetylgalactosamine-4-Sulfatase
Cerebroside-Sulfatase
Glucosylceramidase
Adrenoleukodystrophy
Y Chromosome
X Chromosome
Fluorescence In Situ Hybridization
Microsatellite Repeats
Proteins
Genotype

Keywords

  • Allogenic bone marrow
  • Hematopoietic stem cell
  • Mesenchymal stem cell
  • Storage disease
  • Stromal cells

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. / Koç, Omer N.; Peters, Charles; Aubourg, Patrick; Raghavan, Shrini; Dyhouse, Stephanie; Degasperi, Rita; Kolodny, Edwin H.; Benyoseph, Yoav; Gerson, Stanton L.; Lazarus, Hillard M.; Caplan, Arnold I.; Watkins, Paul A; Krivit, William.

In: Experimental Hematology, Vol. 27, No. 11, 11.1999, p. 1675-1681.

Research output: Contribution to journalArticle

Koç, ON, Peters, C, Aubourg, P, Raghavan, S, Dyhouse, S, Degasperi, R, Kolodny, EH, Benyoseph, Y, Gerson, SL, Lazarus, HM, Caplan, AI, Watkins, PA & Krivit, W 1999, 'Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases', Experimental Hematology, vol. 27, no. 11, pp. 1675-1681. https://doi.org/10.1016/S0301-472X(99)00101-0
Koç, Omer N. ; Peters, Charles ; Aubourg, Patrick ; Raghavan, Shrini ; Dyhouse, Stephanie ; Degasperi, Rita ; Kolodny, Edwin H. ; Benyoseph, Yoav ; Gerson, Stanton L. ; Lazarus, Hillard M. ; Caplan, Arnold I. ; Watkins, Paul A ; Krivit, William. / Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. In: Experimental Hematology. 1999 ; Vol. 27, No. 11. pp. 1675-1681.
@article{d7957eff7e8e4c6a8a902c5a70c183b2,
title = "Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases",
abstract = "Human bone marrow contains mesenchymal stem cells (MSCs) that can differentiate into various cells of mesenchymal origin. We developed an efficient method of isolating and culture expanding a homogenous population of MSCs from bone marrow and determined that MSCs express α-L-iduronidase, arylsulfatase-A and B, glucocerebrosidase, and adrenoleukodystrophy protein. These findings raised the possibility that MSCs may be useful in the treatment of storage disorders. To determine if donor derived MSCs are transferred to the recipients with lysosomal or peroxisomal storage diseases by allogeneic hematopoietic stem cell (HSC) transplantation, we investigated bone marrow derived MSCs of 13 patients 1-14 years after allogeneic transplantation. Highly purified MSCs were genotyped either by fluorescence in situ hybridization using probes for X and Y-chromosomes in gender mis- matched recipients or by radiolabeled PCR amplification of polymorphic simple sequence repeats. Phenotype was determined by the measurement of disease specific protein/enzyme activity in purified MSCs. We found that MSCs isolated from recipients of allogeneic HSC transplantation are not of donor genotype and have persistent phenotypic defects despite successful donor type hematopoietic engraftment. Whether culture expanded normal MSCs can be successfully transplanted into patients with storage diseases and provide therapeutic benefit needs to be determined.",
keywords = "Allogenic bone marrow, Hematopoietic stem cell, Mesenchymal stem cell, Storage disease, Stromal cells",
author = "Ko{\cc}, {Omer N.} and Charles Peters and Patrick Aubourg and Shrini Raghavan and Stephanie Dyhouse and Rita Degasperi and Kolodny, {Edwin H.} and Yoav Benyoseph and Gerson, {Stanton L.} and Lazarus, {Hillard M.} and Caplan, {Arnold I.} and Watkins, {Paul A} and William Krivit",
year = "1999",
month = "11",
doi = "10.1016/S0301-472X(99)00101-0",
language = "English (US)",
volume = "27",
pages = "1675--1681",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases

AU - Koç, Omer N.

AU - Peters, Charles

AU - Aubourg, Patrick

AU - Raghavan, Shrini

AU - Dyhouse, Stephanie

AU - Degasperi, Rita

AU - Kolodny, Edwin H.

AU - Benyoseph, Yoav

AU - Gerson, Stanton L.

AU - Lazarus, Hillard M.

AU - Caplan, Arnold I.

AU - Watkins, Paul A

AU - Krivit, William

PY - 1999/11

Y1 - 1999/11

N2 - Human bone marrow contains mesenchymal stem cells (MSCs) that can differentiate into various cells of mesenchymal origin. We developed an efficient method of isolating and culture expanding a homogenous population of MSCs from bone marrow and determined that MSCs express α-L-iduronidase, arylsulfatase-A and B, glucocerebrosidase, and adrenoleukodystrophy protein. These findings raised the possibility that MSCs may be useful in the treatment of storage disorders. To determine if donor derived MSCs are transferred to the recipients with lysosomal or peroxisomal storage diseases by allogeneic hematopoietic stem cell (HSC) transplantation, we investigated bone marrow derived MSCs of 13 patients 1-14 years after allogeneic transplantation. Highly purified MSCs were genotyped either by fluorescence in situ hybridization using probes for X and Y-chromosomes in gender mis- matched recipients or by radiolabeled PCR amplification of polymorphic simple sequence repeats. Phenotype was determined by the measurement of disease specific protein/enzyme activity in purified MSCs. We found that MSCs isolated from recipients of allogeneic HSC transplantation are not of donor genotype and have persistent phenotypic defects despite successful donor type hematopoietic engraftment. Whether culture expanded normal MSCs can be successfully transplanted into patients with storage diseases and provide therapeutic benefit needs to be determined.

AB - Human bone marrow contains mesenchymal stem cells (MSCs) that can differentiate into various cells of mesenchymal origin. We developed an efficient method of isolating and culture expanding a homogenous population of MSCs from bone marrow and determined that MSCs express α-L-iduronidase, arylsulfatase-A and B, glucocerebrosidase, and adrenoleukodystrophy protein. These findings raised the possibility that MSCs may be useful in the treatment of storage disorders. To determine if donor derived MSCs are transferred to the recipients with lysosomal or peroxisomal storage diseases by allogeneic hematopoietic stem cell (HSC) transplantation, we investigated bone marrow derived MSCs of 13 patients 1-14 years after allogeneic transplantation. Highly purified MSCs were genotyped either by fluorescence in situ hybridization using probes for X and Y-chromosomes in gender mis- matched recipients or by radiolabeled PCR amplification of polymorphic simple sequence repeats. Phenotype was determined by the measurement of disease specific protein/enzyme activity in purified MSCs. We found that MSCs isolated from recipients of allogeneic HSC transplantation are not of donor genotype and have persistent phenotypic defects despite successful donor type hematopoietic engraftment. Whether culture expanded normal MSCs can be successfully transplanted into patients with storage diseases and provide therapeutic benefit needs to be determined.

KW - Allogenic bone marrow

KW - Hematopoietic stem cell

KW - Mesenchymal stem cell

KW - Storage disease

KW - Stromal cells

UR - http://www.scopus.com/inward/record.url?scp=0032697409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032697409&partnerID=8YFLogxK

U2 - 10.1016/S0301-472X(99)00101-0

DO - 10.1016/S0301-472X(99)00101-0

M3 - Article

VL - 27

SP - 1675

EP - 1681

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 11

ER -